813 related articles for article (PubMed ID: 25282191)
21. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass.
Korner J; Inabnet W; Febres G; Conwell IM; McMahon DJ; Salas R; Taveras C; Schrope B; Bessler M
Int J Obes (Lond); 2009 Jul; 33(7):786-95. PubMed ID: 19417773
[TBL] [Abstract][Full Text] [Related]
22. Peptide YY levels are elevated after gastric bypass surgery.
Chan JL; Mun EC; Stoyneva V; Mantzoros CS; Goldfine AB
Obesity (Silver Spring); 2006 Feb; 14(2):194-8. PubMed ID: 16571843
[TBL] [Abstract][Full Text] [Related]
23. Similar Gut Hormone Secretions Two Years After One Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass: a Pilot Study.
De Bandt D; Rives-Lange C; Frigout Y; Bergerot D; Blanchard A; Le Gall M; Lacorte JM; Chevallier JM; Czernichow S; Poghosyan T; Carette C; Le Beyec J
Obes Surg; 2022 Mar; 32(3):757-762. PubMed ID: 34993850
[TBL] [Abstract][Full Text] [Related]
24. Fasting glycemia: a good predictor of weight loss after RYGB.
Faria G; Preto J; Almeida AB; Guimarães JT; Calhau C; Taveira-Gomes A
Surg Obes Relat Dis; 2014; 10(3):419-24. PubMed ID: 24462312
[TBL] [Abstract][Full Text] [Related]
25. Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes.
Rhee NA; Wahlgren CD; Pedersen J; Mortensen B; Langholz E; Wandall EP; Friis SU; Vilmann P; Paulsen SJ; Kristiansen VB; Jelsing J; Dalbøge LS; Poulsen SS; Holst JJ; Vilsbøll T; Knop FK
Diabetologia; 2015 Oct; 58(10):2254-8. PubMed ID: 26186884
[TBL] [Abstract][Full Text] [Related]
26. The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers.
Tan T; Behary P; Tharakan G; Minnion J; Al-Najim W; Albrechtsen NJW; Holst JJ; Bloom SR
J Clin Endocrinol Metab; 2017 Jul; 102(7):2364-2372. PubMed ID: 28379519
[TBL] [Abstract][Full Text] [Related]
27. Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study.
Whitson BA; Leslie DB; Kellogg TA; Maddaus MA; Buchwald H; Billington CJ; Ikramuddin S
J Surg Res; 2007 Jul; 141(1):31-9. PubMed ID: 17574036
[TBL] [Abstract][Full Text] [Related]
28. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial.
Peterli R; Wölnerhanssen B; Peters T; Devaux N; Kern B; Christoffel-Courtin C; Drewe J; von Flüe M; Beglinger C
Ann Surg; 2009 Aug; 250(2):234-41. PubMed ID: 19638921
[TBL] [Abstract][Full Text] [Related]
29. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery.
Beckman LM; Beckman TR; Sibley SD; Thomas W; Ikramuddin S; Kellogg TA; Ghatei MA; Bloom SR; le Roux CW; Earthman CP
JPEN J Parenter Enteral Nutr; 2011 Mar; 35(2):169-80. PubMed ID: 21378246
[TBL] [Abstract][Full Text] [Related]
30. A Meta-Analysis of GLP-1 After Roux-En-Y Gastric Bypass: Impact of Surgical Technique and Measurement Strategy.
Jirapinyo P; Jin DX; Qazi T; Mishra N; Thompson CC
Obes Surg; 2018 Mar; 28(3):615-626. PubMed ID: 28871519
[TBL] [Abstract][Full Text] [Related]
31. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
[TBL] [Abstract][Full Text] [Related]
32. Relevance of beta-cell function for improved glycemic control after gastric bypass surgery.
Blanco J; Jiménez A; Casamitjana R; Flores L; Lacy A; Conget I; Vidal J
Surg Obes Relat Dis; 2014; 10(1):9-13; quiz 189-90. PubMed ID: 24342036
[TBL] [Abstract][Full Text] [Related]
33. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.
le Roux CW; Aylwin SJ; Batterham RL; Borg CM; Coyle F; Prasad V; Shurey S; Ghatei MA; Patel AG; Bloom SR
Ann Surg; 2006 Jan; 243(1):108-14. PubMed ID: 16371744
[TBL] [Abstract][Full Text] [Related]
34. Mucosal glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide cell numbers in the super-obese human foregut after gastric bypass.
Nergård BJ; Lindqvist A; Gislason HG; Groop L; Ekelund M; Wierup N; Hedenbro JL
Surg Obes Relat Dis; 2015; 11(6):1237-46. PubMed ID: 26143297
[TBL] [Abstract][Full Text] [Related]
35. Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation.
le Roux CW; Borg C; Wallis K; Vincent RP; Bueter M; Goodlad R; Ghatei MA; Patel A; Bloom SR; Aylwin SJ
Ann Surg; 2010 Jul; 252(1):50-6. PubMed ID: 20562614
[TBL] [Abstract][Full Text] [Related]
36. Distinct adaptations of endocrine and cognitive functions may contribute to high variability in long-term weight loss outcome after bariatric surgery.
Lammert M; Medawar E; Hartmann H; Grasser L; Dietrich A; Fenske W; Horstmann A
Physiol Behav; 2023 Oct; 269():114279. PubMed ID: 37356514
[TBL] [Abstract][Full Text] [Related]
37. Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake.
Bojsen-Møller KN; Svane MS; Martinussen C; Dirksen C; Jørgensen NB; Jensen JB; Jensen CZ; Torekov SS; Kristiansen VB; Rehfeld JF; Bork-Jensen J; Grarup N; Hansen T; Hartmann B; Holst JJ; Madsbad S
Int J Obes (Lond); 2023 Nov; 47(11):1143-1151. PubMed ID: 37653071
[TBL] [Abstract][Full Text] [Related]
38. Suboptimal Weight Loss 13 Years After Roux-en-Y Gastric Bypass Is Associated with Blunted Appetite Response.
Nymo S; Lundanes J; Eriksen K; Aukan M; Rehfeld JF; Holst JJ; Johnsen G; Græslie H; Kulseng B; Sandvik J; Martins C
Obes Surg; 2024 Feb; 34(2):592-601. PubMed ID: 38159146
[TBL] [Abstract][Full Text] [Related]
39. The gut hormone response following Roux-en-Y gastric bypass: cross-sectional and prospective study.
Pournaras DJ; Osborne A; Hawkins SC; Mahon D; Ghatei MA; Bloom SR; Welbourn R; le Roux CW
Obes Surg; 2010 Jan; 20(1):56-60. PubMed ID: 19826888
[TBL] [Abstract][Full Text] [Related]
40. Roux-en-Y gastric bypass attenuates the progression of cardiometabolic complications in obese diabetic rats via alteration in gastrointestinal hormones.
Lau RG; Kumar S; Hall CE; Palaia T; Rideout DA; Hall K; Brathwaite CE; Ragolia L
Surg Obes Relat Dis; 2015; 11(5):1044-53. PubMed ID: 25980330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
